Open access · CC-BY
via OpenAlex
Telomerase – future drug target enzyme?
Slovenian Medical Journal · 2012
Abstract
Eucaryotic chromosome endings (telomeres) replication problem was solved in the 1980’s by discovery of the telomerase enzyme. The Nobel Prize in Physiology or Medicine was awarded in 2009 for the discovery of telomerase. Altered telomerase expression in cancer, and human dream of eternal youth have accelerated the development of pharmacological telomerase inhibitors and activators. However, after 15 years of development they are still not available on the market. In the present article we reviewed pharmacological agents that target telomerase activity, which have entered clinical trials. Current drugs in development are mostly not intended to be used alone, as telomerase inhibitors under clinical trials are used in combination with the existing chemotherapeutics and anti-telomerase vaccines in combination with immuno-stimulants. Apart from cancer and aging, there are other diseases linked to deregulated activity of telomerase/telomeres and we also discuss technical and legal problems that researchers encounter in developing anti-telomerase therapy. Given the pace of development, first anti-telomerase drugs might appear on the market in the next 5 years.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- Canonical
- link ↗
- Fetched
- 2026-10-10 MST
Cite this
APA
Langerholc, T. (2012). Telomerase – future drug target enzyme?. <em>Slovenian Medical Journal</em>. https://openalex.org/W1882938567
Vancouver
Langerholc T. Telomerase – future drug target enzyme?. Slovenian Medical Journal. 2012.
BibTeX
@article{toma2012Telome,
title = {Telomerase – future drug target enzyme?},
author = {Tomaž Langerholc},
journal = {Slovenian Medical Journal},
year = {2012},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Molecular Biology Reports 2010
Open access · CC-BY
Human telomerase activity regulation
Pharmacological Research 2016
Preprint · OA
Friend or foe? Telomerase as a pharmacological target in cancer and cardiovascular disease
Medicinal Research Reviews 2020
Preprint · OA
Targeting telomerase for its advent in cancer therapeutics
The EMBO Journal 2009
Open access · OA
Telomeres and disease
Nucleic Acids Research 2010
Open access · CC-BY
InTERTpreting telomerase structure and function
Molecular Medicine Today 1995
Citation only